Nebu George Thomas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nebu George Thomas has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
Nibu Varghese
Stem cell and tissue engineering lab, Pushpagiri Research Center, Pushpagiri Institute of Medical Sciences and Research Centre, Tiruvalla, India
5 shared publications- Raneesh Balakrishnan
Department of Physics Catholicate College Pathanamthitta Kerala India
5 shared publications - Sukumaran Anil
Dental Research Cell, Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth (deemed to be University), Pimpri, Pune, India
5 shared publications Anju Rajan
Catholicate College
4 shared publicationsRani Shine Raju
KPR Institute of Engineering and Technology
4 shared publications- Avneesh Chopra
Department of Conservative Dentistry and Periodontology, Medizinische Hochschule Brandenburg (MHB) Theodor Fontane, Brandenburg an der Havel, Germany
3 shared publications
Latest Publications
- 21 September 2026
- Published by Wiley in Macromolecular Bioscience
- Vol. 26 (9) , e70259
Fabrication and Healing Potential of Polylactic Acid /Clay/Nd 2 O 3 Nanocomposite Fibers in Diabetic Wound Therapy
Chronic diabetic wounds are difficult to heal due to impaired neovascularization, dysregulated tissue repair, and prolonged inflammation. To address these challenges, PLA/nanoclay/Nd 2 O 3 nanocomposite fiber mats were fabricated by electrospinning. Structural and morphological analyses confirmed successful incorporation and uniform dispersion of nanoclay and Nd 2 O 3 within the PLA matrix. Nanoclay modulated the scaffold surface, while Nd 2 O 3 enhanced mechanical strength. The intercalated nanoclay network further improved load transfer, reduced fiber diameter, and enhanced surface wettability, supporting cellular interactions. The scaffold showed more than 90% cell viability across all tested samples, demonstrating good cytocompatibility. The optimized scaffold exhibited significant antibacterial activity against methicillin‐resistant Staphylococcus aureus (MRSA). The enhanced vascular density of the scaffolds in the chick chorioallantoic membrane (CAM) assay confirms their angiogenic potential. The scaffold also demonstrated controlled degradation, with 8.1 ± 0.5% weight loss after 28 days in simulated body fluid. In vivo evaluation using a diabetic rat wound model showed accelerated wound contraction, complete reepithelialization, neovascularization and minimal inflammatory response by day 21. The findings of this study suggest that PLA/Clay/Nd 2 O 3 bioactive nanofibrous scaffolds have considerable potential for diabetic wound‐healing applications.
- 21 September 2026
- Published by Wiley in Macromolecular Bioscience
- Vol. 26 (9) , e70259
Fabrication and Healing Potential of Polylactic Acid /Clay/Nd 2 O 3 Nanocomposite Fibers in Diabetic Wound Therapy
Chronic diabetic wounds are difficult to heal due to impaired neovascularization, dysregulated tissue repair, and prolonged inflammation. To address these challenges, PLA/nanoclay/Nd 2 O 3 nanocomposite fiber mats were fabricated by electrospinning. Structural and morphological analyses confirmed successful incorporation and uniform dispersion of nanoclay and Nd 2 O 3 within the PLA matrix. Nanoclay modulated the scaffold surface, while Nd 2 O 3 enhanced mechanical strength. The intercalated nanoclay network further improved load transfer, reduced fiber diameter, and enhanced surface wettability, supporting cellular interactions. The scaffold showed more than 90% cell viability across all tested samples, demonstrating good cytocompatibility. The optimized scaffold exhibited significant antibacterial activity against methicillin‐resistant Staphylococcus aureus (MRSA). The enhanced vascular density of the scaffolds in the chick chorioallantoic membrane (CAM) assay confirms their angiogenic potential. The scaffold also demonstrated controlled degradation, with 8.1 ± 0.5% weight loss after 28 days in simulated body fluid. In vivo evaluation using a diabetic rat wound model showed accelerated wound contraction, complete reepithelialization, neovascularization and minimal inflammatory response by day 21. The findings of this study suggest that PLA/Clay/Nd 2 O 3 bioactive nanofibrous scaffolds have considerable potential for diabetic wound‐healing applications.
- 20 July 2026
- Published by IOP Publishing in Biomedical Materials
- Vol. 21 (4) , 045015
Biomimetic electrospun PLA nanocomposite fibers reinforced with CNT and Fe 2 O 3 dual fillers for enhanced multifunctional performance
This study reports the fabrication of polylactic acid (PLA)-based biopolymer nanocomposite fibers reinforced with functionalized multi-walled carbon nanotubes (CNTs) and iron oxide (Fe 2 O 3 ) nanoparticles to enhance both mechanical and electrical properties through dual-filler reinforcement. The electrospun fibers were characterized using mechanical testing, FTIR, field-emission scanning electron microscopy, XRD, differential scanning calorimetry measurements, and polarization-electric field (P-E) hysteresis measurements to understand how the incorporation of CNTs and Fe 2 O 3 influenced fiber morphology, crystallinity, and functional behavior. Morphological and structural analyses confirmed the presence of continuous, bead-free fibers with a highly porous nanoscale fibrous network. The decrease in fiber diameter and enhanced dipolar alignment contributed to improved electrical polarization behavior. Due to the inherent biocompatibility of PLA and its relevance in biomedical devices, the biocompatibility and toxicity of the developed PLA/CNT/Fe 2 O 3 nanocomposite fibers were evaluated. In vitro cell studies, along with short-term in vivo implantation and acute toxicity assessments, indicated favorable biocompatibility and absence of acute systemic toxicity. Together, these results demonstrate that PLA/CNT/Fe 2 O 3 nanocomposite fiber mats exhibit improved mechanical and electrical polarization characteristics with acceptable short-term biological response.
- 20 July 2026
- Published by IOP Publishing in Biomedical Materials
- Vol. 21 (4) , 045015
Biomimetic electrospun PLA nanocomposite fibers reinforced with CNT and Fe 2 O 3 dual fillers for enhanced multifunctional performance
This study reports the fabrication of polylactic acid (PLA)-based biopolymer nanocomposite fibers reinforced with functionalized multi-walled carbon nanotubes (CNTs) and iron oxide (Fe 2 O 3 ) nanoparticles to enhance both mechanical and electrical properties through dual-filler reinforcement. The electrospun fibers were characterized using mechanical testing, FTIR, field-emission scanning electron microscopy, XRD, differential scanning calorimetry measurements, and polarization-electric field (P-E) hysteresis measurements to understand how the incorporation of CNTs and Fe 2 O 3 influenced fiber morphology, crystallinity, and functional behavior. Morphological and structural analyses confirmed the presence of continuous, bead-free fibers with a highly porous nanoscale fibrous network. The decrease in fiber diameter and enhanced dipolar alignment contributed to improved electrical polarization behavior. Due to the inherent biocompatibility of PLA and its relevance in biomedical devices, the biocompatibility and toxicity of the developed PLA/CNT/Fe 2 O 3 nanocomposite fibers were evaluated. In vitro cell studies, along with short-term in vivo implantation and acute toxicity assessments, indicated favorable biocompatibility and absence of acute systemic toxicity. Together, these results demonstrate that PLA/CNT/Fe 2 O 3 nanocomposite fiber mats exhibit improved mechanical and electrical polarization characteristics with acceptable short-term biological response.
- 30 January 2026
- Published by SAGE Publications in Journal of Biomaterials Applications
Development and evaluation of a fish skin-derived acellular dermal matrix for diabetic wound healing: In vitro and in vivo assessment
Introduction: Non-healing diabetic foot ulcers often result in amputation and reduced quality of life. The study objective was to develop and evaluate a novel fish skin-derived acellular dermal matrix (FSADM) for diabetic wound-healing applications, addressing these challenges. Methods: FSADM was fabricated from yellow fin tuna ( Thunnus albacares ) skin using a decellularization and lyophilization process. The matrix was characterized by Fourier-transform infrared spectroscopy (FTIR). In vitro biocompatibility was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays with L929 fibroblasts and hemocompatibility tests. In vivo , biocompatibility was evaluated through subcutaneous implantation in Sprague-Dawley rats. Wound-healing efficacy was assessed in a streptozotocin-induced diabetic rat model with full-thickness excisional wounds, comparing FSADM with commercial alternatives and untreated controls. Results: FTIR analysis confirmed the preservation of collagen structure in FSADM. In vitro studies demonstrated cytocompatibility with L929 cells and minimal haemolytic activity (0.68 ± 0.034%). Subcutaneous implantation demonstrated good biocompatibility, with a progressive reduction in the inflammatory response. In the diabetic wound model, FSADM-treated wounds exhibited significantly faster closure rates than commercial controls ( p < 0.05), achieving 100% closure by day 21, compared to 90% closure in commercial controls. Histological analysis revealed enhanced epithelialization, hair follicle formation, and angiogenesis in FSADM-treated wounds. Conclusion: FSADM demonstrates excellent biocompatibility and superior wound-healing in diabetic conditions compared to commercial alternatives. It presents a promising, sustainable biomaterial for diabetic wound care. Further studies are needed to validate these findings in clinical settings and optimize their therapeutic potential.
- 30 January 2026
- Published by SAGE Publications in Journal of Biomaterials Applications
Development and evaluation of a fish skin-derived acellular dermal matrix for diabetic wound healing: In vitro and in vivo assessment
Introduction: Non-healing diabetic foot ulcers often result in amputation and reduced quality of life. The study objective was to develop and evaluate a novel fish skin-derived acellular dermal matrix (FSADM) for diabetic wound-healing applications, addressing these challenges. Methods: FSADM was fabricated from yellow fin tuna ( Thunnus albacares ) skin using a decellularization and lyophilization process. The matrix was characterized by Fourier-transform infrared spectroscopy (FTIR). In vitro biocompatibility was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays with L929 fibroblasts and hemocompatibility tests. In vivo , biocompatibility was evaluated through subcutaneous implantation in Sprague-Dawley rats. Wound-healing efficacy was assessed in a streptozotocin-induced diabetic rat model with full-thickness excisional wounds, comparing FSADM with commercial alternatives and untreated controls. Results: FTIR analysis confirmed the preservation of collagen structure in FSADM. In vitro studies demonstrated cytocompatibility with L929 cells and minimal haemolytic activity (0.68 ± 0.034%). Subcutaneous implantation demonstrated good biocompatibility, with a progressive reduction in the inflammatory response. In the diabetic wound model, FSADM-treated wounds exhibited significantly faster closure rates than commercial controls ( p < 0.05), achieving 100% closure by day 21, compared to 90% closure in commercial controls. Histological analysis revealed enhanced epithelialization, hair follicle formation, and angiogenesis in FSADM-treated wounds. Conclusion: FSADM demonstrates excellent biocompatibility and superior wound-healing in diabetic conditions compared to commercial alternatives. It presents a promising, sustainable biomaterial for diabetic wound care. Further studies are needed to validate these findings in clinical settings and optimize their therapeutic potential.
- 31 December 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 690, 126533
Engineered core-shell nanocomposite fibres incorporating bio-ceramics and bioactive molecules for wound repair
- 31 December 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 690, 126533
Engineered core-shell nanocomposite fibres incorporating bio-ceramics and bioactive molecules for wound repair
- 10 December 2025
- Published by Wiley in Biopolymers
- Vol. 117 (1) , e70069
TiO 2 Nanoparticles—Incorporated PCL /Gelatin Nanocomposite Fibers for Enhanced Biocompatibility and Reduced Foreign Body Response
The foreign body response (FBR) is a major hurdle in the success of biomedical implants, often leading to persistent inflammation and eventual rejection. Developing biomaterials that can minimize immune reactions while supporting tissue healing is essential. In this study, nanocomposite fibers composed of polycaprolactone (PCL) and gelatin, reinforced with titanium dioxide (TiO 2 ) nanoparticles, were fabricated using electrospinning. The fibers were evaluated for their morphology, structural properties, and mechanical strength using field emission scanning electron microscopy (FE‐SEM), X‐ray diffraction (XRD), Fourier‐transform infrared (FTIR) spectroscopy, and a universal testing machine (UTM). In vitro cytocompatibility was assessed using the MTT assay on L929 fibroblast cells. For in vivo analysis, subcutaneous implantation was carried out in Sprague–Dawley rats, followed by histological examination at weekly intervals for 4 weeks. The fibers displayed good mechanical properties, a uniform surface morphology, and a consistent structure. The in vitro results indicated high cell viability with no signs of toxicity. In vivo studies revealed reduced macrophage accumulation and enhanced fibroblast activity, indicating a favorable immune response and tissue integration. TiO 2 ‐incorporated PCL/gelatin nanocomposite fibers demonstrated excellent biocompatibility, minimal immune reaction, and effective tissue response, highlighting their potential as advanced materials for biomedical implant applications.
- 10 December 2025
- Published by Wiley in Biopolymers
- Vol. 117 (1) , e70069
TiO 2 Nanoparticles—Incorporated PCL /Gelatin Nanocomposite Fibers for Enhanced Biocompatibility and Reduced Foreign Body Response
The foreign body response (FBR) is a major hurdle in the success of biomedical implants, often leading to persistent inflammation and eventual rejection. Developing biomaterials that can minimize immune reactions while supporting tissue healing is essential. In this study, nanocomposite fibers composed of polycaprolactone (PCL) and gelatin, reinforced with titanium dioxide (TiO 2 ) nanoparticles, were fabricated using electrospinning. The fibers were evaluated for their morphology, structural properties, and mechanical strength using field emission scanning electron microscopy (FE‐SEM), X‐ray diffraction (XRD), Fourier‐transform infrared (FTIR) spectroscopy, and a universal testing machine (UTM). In vitro cytocompatibility was assessed using the MTT assay on L929 fibroblast cells. For in vivo analysis, subcutaneous implantation was carried out in Sprague–Dawley rats, followed by histological examination at weekly intervals for 4 weeks. The fibers displayed good mechanical properties, a uniform surface morphology, and a consistent structure. The in vitro results indicated high cell viability with no signs of toxicity. In vivo studies revealed reduced macrophage accumulation and enhanced fibroblast activity, indicating a favorable immune response and tissue integration. TiO 2 ‐incorporated PCL/gelatin nanocomposite fibers demonstrated excellent biocompatibility, minimal immune reaction, and effective tissue response, highlighting their potential as advanced materials for biomedical implant applications.
- Open Access
- 14 November 2025
- Published by Springer Nature in European Archives of Paediatric Dentistry
- Vol. 27 (1) , 159-169
Oral health disparities among children with special healthcare needs: a comparative cross-sectional study
Purpose: Children with special healthcare needs (SHCN) often experience poorer oral health due to limitations in self-care, behavioral challenges, medical conditions, and reduced access to specialized dental services. This study aimed to assess and compare oral health behaviors, risk factors, and caries experience between children with SHCN and healthy controls, and to identify predictors of poor oral health outcomes. Method: In this cross-sectional study, 300 children (150 SHCN, 150 controls) underwent clinical examinations. Caries experience was assessed using the decayed, missing, and filled teeth (dmft/DMFT) indices, while oral hygiene status was evaluated with the Plaque Index and Gingival Index. Occlusal characteristics, dental trauma, and oral habits were also recorded. Behavioral assessment was performed using the Frankl Behavior Rating Scale (FBRS). Results: Children with SHCN demonstrated higher resistance to toothbrushing (42.7% vs. 6.7%, p = 0.001), more frequent swallowing of toothpaste (32.0% vs. 0%, p = 0.001), and a greater prevalence of habits such as mouth breathing (30.7% vs. 8.7%, p = 0.001). Interestingly, the control group showed significantly higher mean dmft scores (5.07 ± 3.56) compared to SHCN children (2.64 ± 4.22, p = 0.001). Regression analysis identified group (B = 2.44, p < 0.001) and age (B = − 0.125, p = 0.002) as significant predictors, explaining 12.2% of the variance. SHCN children exhibited distinct behavioral risk factors, while younger age was associated with higher caries experience. Conclusion: Children with SHCN exhibited significantly poorer oral health behaviors, including resistance to brushing, swallowing toothpaste, and abnormal oral habits, compared to controls. Interestingly, despite these behavioral disadvantages, caries experience was higher in the control group, underscoring the multifactorial and complex nature of caries development. Group type and age emerged as significant predictors of dmft.
- 14 November 2025
- Published by Springer Nature in European Archives of Paediatric Dentistry
- Vol. 27 (1) , 159-169
Open AccessOral health disparities among children with special healthcare needs: a comparative cross-sectional study
Purpose: Children with special healthcare needs (SHCN) often experience poorer oral health due to limitations in self-care, behavioral challenges, medical conditions, and reduced access to specialized dental services. This study aimed to assess and compare oral health behaviors, risk factors, and caries experience between children with SHCN and healthy controls, and to identify predictors of poor oral health outcomes. Method: In this cross-sectional study, 300 children (150 SHCN, 150 controls) underwent clinical examinations. Caries experience was assessed using the decayed, missing, and filled teeth (dmft/DMFT) indices, while oral hygiene status was evaluated with the Plaque Index and Gingival Index. Occlusal characteristics, dental trauma, and oral habits were also recorded. Behavioral assessment was performed using the Frankl Behavior Rating Scale (FBRS). Results: Children with SHCN demonstrated higher resistance to toothbrushing (42.7% vs. 6.7%, p = 0.001), more frequent swallowing of toothpaste (32.0% vs. 0%, p = 0.001), and a greater prevalence of habits such as mouth breathing (30.7% vs. 8.7%, p = 0.001). Interestingly, the control group showed significantly higher mean dmft scores (5.07 ± 3.56) compared to SHCN children (2.64 ± 4.22, p = 0.001). Regression analysis identified group (B = 2.44, p < 0.001) and age (B = − 0.125, p = 0.002) as significant predictors, explaining 12.2% of the variance. SHCN children exhibited distinct behavioral risk factors, while younger age was associated with higher caries experience. Conclusion: Children with SHCN exhibited significantly poorer oral health behaviors, including resistance to brushing, swallowing toothpaste, and abnormal oral habits, compared to controls. Interestingly, despite these behavioral disadvantages, caries experience was higher in the control group, underscoring the multifactorial and complex nature of caries development. Group type and age emerged as significant predictors of dmft.
- Open Access
- 9 October 2025
- Published by Springer Nature in BDJ Open
- Vol. 11 (1) , 1-10
In vitro and in vivo biocompatibility of a porcine cholecystic extracellular matrix (CECM) membrane for tissue regeneration
Background: Periodontal disease affects 3.5 billion people globally, resulting in annual treatment costs exceeding $54 billion. Guided tissue regeneration (GTR) membranes are essential for periodontal therapy, but commercially available options often suffer from limitations, including high cost, limited accessibility in resource-limited settings, and suboptimal mechanical properties. This study aimed to develop and characterize a novel porcine cholecystic extracellular matrix (CECM)-based GTR membrane and comprehensively evaluate its physicochemical properties, cytocompatibility, and in vivo biocompatibility compared to the commercially available Healiguide® membrane. Methods: CECM membranes were fabricated through systematic decellularization, lyophilization, and ethylene oxide (ETO) sterilization of porcine gallbladders. Surface characterization was performed using scanning electron microscopy (SEM) with quantitative pore analysis, and biochemical composition was assessed via Fourier Transform Infrared Spectroscopy (FTIR). MTT assays were performed on L929 fibroblast cells to evaluate cytocompatibility. Wound healing capacity was assessed using scratch assays monitored over 72 h. In vivo biocompatibility was evaluated through subcutaneous implantation in Sprague-Dawley rats, with histological analysis performed at 1, 2, 3, and 4 weeks post-implantation. Results: SEM analysis revealed that CECM membranes exhibited a heterogeneous, multilayered structure with larger average pore sizes compared to Healiguide® (18.2 ± 4.6 µm vs. 12.5 ± 3.2 µm, p < 0.05), facilitating enhanced cellular infiltration. FTIR confirmed the preserved integrity of collagen in both membranes, with CECM showing an enhanced glycoprotein content indicative of retained bioactive components. Cytocompatibility assessment demonstrated excellent cell viability for CECM, showing 97.4 ± 1.6%, 94.2 ± 1.8%, and 90.8 ± 1.4% viability at 20, 50, and 100 µg/mL CECM extracts, respectively. The scratch assay demonstrated superior wound healing capacity for CECM, with significantly enhanced wound closure at 72 h compared to Healiguide® (89.7 ± 6.1% vs. 79.4 ± 5.8%, p < 0.05). Subcutaneous implantation studies confirmed excellent in vivo biocompatibility, with CECM showing lower initial inflammatory response (inflammation score: 2.3 ± 0.5 vs 2.8 ± 0.6 at week 1, p < 0.05), enhanced vascularization (12.3 ± 2.1 vs 9.7 ± 1.8 vessels/hpf at week 3, p < 0.05), and superior tissue integration compared to commercial controls. Conclusion: The porcine CECM membrane demonstrated favorable physicochemical properties, excellent cytocompatibility, enhanced wound healing potential, and superior tissue integration characteristics compared to commercial GTR membranes. These preliminary findings provide a strong scientific foundation supporting the development of the GTR membrane for periodontal regenerative therapy.
- 9 October 2025
- Published by Springer Nature in BDJ Open
- Vol. 11 (1) , 1-10
Open AccessIn vitro and in vivo biocompatibility of a porcine cholecystic extracellular matrix (CECM) membrane for tissue regeneration
Background: Periodontal disease affects 3.5 billion people globally, resulting in annual treatment costs exceeding $54 billion. Guided tissue regeneration (GTR) membranes are essential for periodontal therapy, but commercially available options often suffer from limitations, including high cost, limited accessibility in resource-limited settings, and suboptimal mechanical properties. This study aimed to develop and characterize a novel porcine cholecystic extracellular matrix (CECM)-based GTR membrane and comprehensively evaluate its physicochemical properties, cytocompatibility, and in vivo biocompatibility compared to the commercially available Healiguide® membrane. Methods: CECM membranes were fabricated through systematic decellularization, lyophilization, and ethylene oxide (ETO) sterilization of porcine gallbladders. Surface characterization was performed using scanning electron microscopy (SEM) with quantitative pore analysis, and biochemical composition was assessed via Fourier Transform Infrared Spectroscopy (FTIR). MTT assays were performed on L929 fibroblast cells to evaluate cytocompatibility. Wound healing capacity was assessed using scratch assays monitored over 72 h. In vivo biocompatibility was evaluated through subcutaneous implantation in Sprague-Dawley rats, with histological analysis performed at 1, 2, 3, and 4 weeks post-implantation. Results: SEM analysis revealed that CECM membranes exhibited a heterogeneous, multilayered structure with larger average pore sizes compared to Healiguide® (18.2 ± 4.6 µm vs. 12.5 ± 3.2 µm, p < 0.05), facilitating enhanced cellular infiltration. FTIR confirmed the preserved integrity of collagen in both membranes, with CECM showing an enhanced glycoprotein content indicative of retained bioactive components. Cytocompatibility assessment demonstrated excellent cell viability for CECM, showing 97.4 ± 1.6%, 94.2 ± 1.8%, and 90.8 ± 1.4% viability at 20, 50, and 100 µg/mL CECM extracts, respectively. The scratch assay demonstrated superior wound healing capacity for CECM, with significantly enhanced wound closure at 72 h compared to Healiguide® (89.7 ± 6.1% vs. 79.4 ± 5.8%, p < 0.05). Subcutaneous implantation studies confirmed excellent in vivo biocompatibility, with CECM showing lower initial inflammatory response (inflammation score: 2.3 ± 0.5 vs 2.8 ± 0.6 at week 1, p < 0.05), enhanced vascularization (12.3 ± 2.1 vs 9.7 ± 1.8 vessels/hpf at week 3, p < 0.05), and superior tissue integration compared to commercial controls. Conclusion: The porcine CECM membrane demonstrated favorable physicochemical properties, excellent cytocompatibility, enhanced wound healing potential, and superior tissue integration characteristics compared to commercial GTR membranes. These preliminary findings provide a strong scientific foundation supporting the development of the GTR membrane for periodontal regenerative therapy.
- Open Access
- 1 December 2024
- Published by Wolters Kluwer Health in Journal of Pharmacy and Bioallied Sciences
- Vol. 16 (Suppl 5) , S4532-S4535
Evaluation of the Anticandidal Effect of Medicinal Plant Extracts to Drug Resistant Candida Albicans Isolates from Type Two Diabetic patients with Stage Three Periodontitis
Objectives: To assess the anticandidal efficacy of nine medicinal plants to drug resistant Candida albicans isolates from diabetic patients with chronic periodontitis. A comparison was done with chlorhexidine gluconate. Methods: Isolates from the periodontal pockets of 121 diabetics with severe periodontitis was obtained. Sensitivity to four antifungal antibiotics was assessed by disc diffusion method. Anticandidal activity of cold ethanol and hot aqueous extracts of nine plants were evaluated by well diffusion method. Minimum inhibitory concentration (MIC) was determined by microtube broth dilution method. Results: C. albicans was found to be the predominant species. None of the isolates extended resistance to amphotericin B. Aqueous and ethanol extracts of Punica granatum, Terminalia bellerica, Terminalia chebula extended notable anticandidal efficacy, and the ethanol extracts were more active. Chlorhexidine extended better efficacy than the plant extracts. Conclusions: C albicans is the prevalent yeast among diabetics with periodontitis. Presence of multidrug resistant for C. albicans is a challenge. P. granatum, T. bellerica and T. chebula can be explored for the development of safer anticandidal agents.
- 1 December 2024
- Published by Wolters Kluwer Health in Journal of Pharmacy and Bioallied Sciences
- Vol. 16 (Suppl 5) , S4532-S4535
Open AccessEvaluation of the Anticandidal Effect of Medicinal Plant Extracts to Drug Resistant Candida Albicans Isolates from Type Two Diabetic patients with Stage Three Periodontitis
Objectives: To assess the anticandidal efficacy of nine medicinal plants to drug resistant Candida albicans isolates from diabetic patients with chronic periodontitis. A comparison was done with chlorhexidine gluconate. Methods: Isolates from the periodontal pockets of 121 diabetics with severe periodontitis was obtained. Sensitivity to four antifungal antibiotics was assessed by disc diffusion method. Anticandidal activity of cold ethanol and hot aqueous extracts of nine plants were evaluated by well diffusion method. Minimum inhibitory concentration (MIC) was determined by microtube broth dilution method. Results: C. albicans was found to be the predominant species. None of the isolates extended resistance to amphotericin B. Aqueous and ethanol extracts of Punica granatum, Terminalia bellerica, Terminalia chebula extended notable anticandidal efficacy, and the ethanol extracts were more active. Chlorhexidine extended better efficacy than the plant extracts. Conclusions: C albicans is the prevalent yeast among diabetics with periodontitis. Presence of multidrug resistant for C. albicans is a challenge. P. granatum, T. bellerica and T. chebula can be explored for the development of safer anticandidal agents.